Single or 2-Dose Micafungin Regimen for Treatment of Invasive Candidiasis: Therapia Sterilisans Magna! (Q28082570)

Clinical Infectious Diseases

published in

1 reference

volume

61 Suppl 6

1 reference

page(s)

S635-42

1 reference

Epidemiology and outcomes of candidemia in 3648 patients: data from the Prospective Antifungal Therapy (PATH Alliance®) registry, 2004-2008.

cites work

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV715

Candida glabrata Fungemia. Clinical features of 139 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV715

International study of the prevalence and outcomes of infection in intensive care units

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV715

Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV715

Impact of therapeutic strategies on the prognosis of candidemia in the ICU.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV715

A multicenter study of septic shock due to candidemia: outcomes and predictors of mortality.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV715

Anidulafungin versus fluconazole for invasive candidiasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV715

Impact of treatment strategy on outcomes in patients with candidemia and other forms of invasive candidiasis: a patient-level quantitative review of randomized trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV715

Discovery of novel antifungal (1,3)-beta-D-glucan synthase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV715

Antibiotics that inhibit fungal cell wall development

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV715

Population pharmacokinetics of micafungin in adult patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV715

Fractal geometry and the pharmacometrics of micafungin in overweight, obese, and extremely obese people

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV715

Intrapulmonary pharmacokinetics and pharmacodynamics of micafungin in adult lung transplant patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV715

Use of pharmacokinetic-pharmacodynamic analyses to optimize therapy with the systemic antifungal micafungin for invasive candidiasis or candidemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV715

Population pharmacokinetics of micafungin in pediatric patients and implications for antifungal dosing

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV715

In vitro susceptibility of invasive isolates of Candida spp. to anidulafungin, caspofungin, and micafungin: six years of global surveillance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV715

Once-weekly micafungin therapy is as effective as daily therapy for disseminated candidiasis in mice with persistent neutropenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV715

In vivo pharmacodynamic target investigation for micafungin against Candida albicans and C. glabrata in a neutropenic murine candidiasis model

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV715

Serum drug concentrations predictive of pulmonary tuberculosis outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV715

Pharmacokinetics of micafungin in healthy volunteers, volunteers with moderate liver disease, and volunteers with renal dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV715

Clinical pharmacodynamic index identification for micafungin in esophageal candidiasis: dosing strategy optimization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV715

Alternate-day micafungin antifungal prophylaxis in pediatric patients undergoing hematopoietic stem cell transplantation: a pharmacokinetic study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV715

Micafungin twice weekly as antifungal prophylaxis in paediatric patients at high risk for invasive fungal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV715

Pharmacokinetic and maximum tolerated dose study of micafungin in combination with fluconazole versus fluconazole alone for prophylaxis of fungal infections in adult patients undergoing a bone marrow or peripheral stem cell transplant

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV715

Impact of pharmacodynamics and pharmacokinetics on echinocandin dosing strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV715

Effect of neutropenia and treatment delay on the response to antifungal agents in experimental disseminated candidiasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV715

Impact on hospital mortality of catheter removal and adequate antifungal therapy in Candida spp. bloodstream infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV715

Impact of rapid organism identification via matrix-assisted laser desorption/ionization time-of-flight combined with antimicrobial stewardship team intervention in adult patients with bacteremia and candidemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV715

Randomized Trial of Rapid Multiplex Polymerase Chain Reaction-Based Blood Culture Identification and Susceptibility Testing.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV715

Detection of triazole resistance among Candida species by matrix-assisted laser desorption/ionization-time of flight mass spectrometry (MALDI-TOF MS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV715

In silico-derived bedside formula for individualized micafungin dosing for obese patients in the age of deterministic chaos

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV715

21 January 2018

Identifiers

DOI

10.1093/CID/CIV715

0 references

PubMed publication ID

26567282

1 reference